Recall: Accord Hydrochlorothiazide Tablets USP 12.5 Mg
On 2018-08-27, the FDA announced that Accord Healthcare is conducting a recall on Hydrochlorothiazide Tablets USP 12.5 Mg due to a possible labeling mix-up. The recalled products were sold under the brand name(s) Accord during an unspecified time period throughout the regions shown in the map below.
In recent months, there have been 1 drugs recalls due to potential labeling mix-up. Additionally, there have been 27 drug and medical device recalls due to other health hazards as well as 69 food recalls.
Company Contact Information:
Name: Accord Healthcare
Do you work for a company involved with this recall? Contact us to learn how you can control data, information and ads shown on this page.
Detailed Recall Information
Regions Where Sold: Because the region was not specified, it is assumed that this product was available nationwide.
Product Description: Hydrochlorothiazide Tablets USP 12.5 mg
Brand Name(s): Accord
Reason for Recall: Labeling mix-up/may contain Spironolactone Tablets
Official Recall Date: 2018-08-27
Additional information provided by the FDA.gov:
Accord Healthcare Inc. is voluntarily recalling One lot (Lot PW05264 - 46632 Bottles, NDC 16729-182-01) of Hydrochlorothiazide Tablets USP, 12.5 mg, to the consumer level. Read More.
More information may be available at FDA.gov
Latest Safety Recalls
Select image for details, including additional styles.
Sources may include Food & Drug Administration (FDA), United States Department of Agriculture (USDA), Health Canada and companies involved with this or a related recall.